Journal Guide

Rheumatology is an international peer review journal publishing the highest quality scientific and clinical papers. The scope of Rheumatology includes a range of rheumatological conditions, musculoskeletal medicine, surgery and translational research. Rheumatology aims to provide very rapid publication of all papers both online and in hard copy.Rheumatology publishes original articles, concise reports, reviews, editorials, guidelines, case reports, clinical vignettes, letters and matters arising from published material.

The international journal Synergy is dedicated to the understanding, development and application of the principle of "synergy" at the molecular, cellular and organismic levels and its application in the prevention and treatment of disease.Multimodal treatments or multitarget approaches are increasingly applied to treat complex diseases in different disciplines of medicine – mainly based on empirical knowledge. There is a need to elucidate and define further the combinatory actions in the context of the theoretical basis, experimental design and quantification of synergy at different dose and effect levels, including optimal combination ratios or sequences and the prevention of potential adverse events.The journal Synergy aims to serve as an international platform for the dissemination, exchange and discourse of innovative research on the systematic development of combination therapies based on synergistic effects and the quantification and quantitative simulation of synergistic and/or antagonistic modes of action. Preclinical and clinical research results are invited from the fields of medicine, molecular and cellular biology, toxicology, pharmacology, pharmacy, and bioinformatics.Synergy publishes research on combinations of single and multicomponent drugs of synthetic or of natural origin. Its scope includes "Omic" approaches, which contribute to the understanding of complex disease traits and bring them into the context of system biology.Synergy welcomes relevant contributions in the forms of original research papers, reviews, rapid communications, perspectives and letters to the editor. Commentaries are by invitation only.

Despite the major efforts made in oncology over the past ten years, only relatively modest improvements have been made in the conventional treatment of cancer. Recently, a better understanding of molecular pathways has provided pathologists with clues to the parthenogenesis of the disease and multiple targets for new strategies. New treatments, monoclonal antibodies or small molecules, have emerged targeting these pathways and inhibiting tumor growth and progression. These 'mabs' and 'nibs' constitute a new language with its own grammar that oncologists have to learn. Significant work remains in controlling theses processes and understanding these new compounds. This journal aims to be a pragmatic tool for all physicians committed to the field, focusing on insight into the basic science of cellular functions, critical reviews of clinical data. The Société française d'angiogenèse is affiliated to the journal.

For more than 50 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on The Journal of Clinical Pharmacology (JCP) for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

NOW ON PUBMED!.The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: arteriosclerosis, cardiomyopathies, coronary artery disease, diabetes, heart failure, hypertension, metabolic syndrome, obesity, peripheral arterial disease, stroke, arrhythmias, genetics. The purpose of the Journal is to publish (in the English language) articles, reviews and scholarly comment which have been judged worthy of publication by appropriate specialists and accepted by the Editor on studies relating to cardiovascular disease, pharmacology and medicine.

Therapeutic Advances in Drug Safety covers novel and controversial aspects pertaining to the safe use of drugs in patients (drug safety, therapeutic drug monitoring, pharmacoepidemiology, adverse drug reactions, drug interactions, pharmacokinetics, pharmacovigilance, medication/prescribing errors, risk management, ethics, regulation). It publishes editorials, perspective reviews, original research (basic and clinical research, negative and positive results), letters, case reports. The Journal encourages the submission of preliminary data and negative studies.

NOW ON PUBMED! Therapeutic Advances in Respiratory Disease is an internationally peer reviewed journal whose primary aim is the dissemination and development of knowledge about the pharmacological treatment of respiratory diseases. The journal`s scope includes emerging therapies for chronic obstructive pulmonary disorder, asthma, pulmonary hypertension and the exacerbations caused by infections and smoking.

Therapeutic Drug Monitoring is an outstanding journal that fosters the exchange of knowledge among the various disciplines--clinical pharmacology, pathology, toxicology, analytical chemistry--that share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs; original articles; case reports; technical notes; and continuing education articles.Published BiMonthlyWebsite: www.drug-monitoring.com.

Trials is an open access, peer-reviewed, online journal that will encompass all aspects of the performance and findings of randomized controlled trials. Trials will experiment with, and then refine, innovative approaches to improving communication about trials.

AJOL is a web platform for African-published journals. It is a partnership of journals committed to increasing the international profile of Africa's scholarly work and improving access to African-originated knowledge. By joining together as a large group of journals, this service has attained great international recognition, and visibility on the internet.

Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds